Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuronetics (STIM) Return on Sales (2017 - 2025)

Historic Return on Sales for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to 0.26%.

  • Neuronetics' Return on Sales rose 2500.0% to 0.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.35%, marking a year-over-year increase of 1300.0%. This contributed to the annual value of 0.56% for FY2024, which is 500.0% down from last year.
  • As of Q3 2025, Neuronetics' Return on Sales stood at 0.26%, which was up 2500.0% from 0.26% recorded in Q2 2025.
  • Over the past 5 years, Neuronetics' Return on Sales peaked at 0.26% during Q3 2025, and registered a low of 0.78% during Q1 2022.
  • For the 5-year period, Neuronetics' Return on Sales averaged around 0.53%, with its median value being 0.53% (2021).
  • Over the last 5 years, Neuronetics' Return on Sales had its largest YoY gain of 3900bps in 2021, and its largest YoY loss of -3200bps in 2021.
  • Over the past 5 years, Neuronetics' Return on Sales (Quarter) stood at 0.53% in 2021, then increased by 7bps to 0.49% in 2022, then skyrocketed by 37bps to 0.31% in 2023, then plummeted by -91bps to 0.59% in 2024, then soared by 57bps to 0.26% in 2025.
  • Its Return on Sales was 0.26% in Q3 2025, compared to 0.26% in Q2 2025 and 0.4% in Q1 2025.